Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2008
10/09/2008US20080248033 VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors
10/09/2008US20080248032 Using 2-acetyl-4-tetrahydroxybutylimidazole (THI) as therapeutic in treatment and prevention of heart and stroke injury
10/09/2008US20080248031 Cell surface molecule mediating cell adhesion and signal transmission
10/09/2008US20080248030 Method of Treating Angiogenic Diseases
10/09/2008US20080248029 Prevention and treatment of amyloidogenic diseases
10/09/2008US20080248028 Immunoadhesin comprising modified Fc gamma R segment for use as targeting diagnostic and/or therapeutic in treatment of cell proliferative disorders
10/09/2008US20080248027 Improving endocytotic efficiency in newborn cattle via admistration of sodium selenite nutrient broth
10/09/2008US20080248026 PTEN/Akt methods and compositions relating to BMP
10/09/2008US20080248025 Gamma Delta T Cells and Methods of Treatment of Interleukin-17 Related Conditions
10/09/2008US20080248024 Using oligonucleotides specific to zinc finger protein 91 (ZFP91) as therapeutic inhibitors in treatment of cell proliferative, inflammatory and gastrointestinal disorders; RNA interference
10/09/2008US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein
10/09/2008US20080248022 Using inflammatory marker concentration as diagnostic/therapeutic indicator for administering vaccine agent for treatment and/or prevention of neurodegenerative disorders
10/09/2008US20080248017 Multicompartment drug delivery system for use in treatment of menopausal symptoms and benign ovarian secretory disorder; contraceptive
10/09/2008US20080248002 Cytokine induced killer cell populations for use in treatment of cell proliferative disordersl; tissue engineering and repair; tissue targeted therapy
10/09/2008US20080247991 Solution Additives For the Attenuation of Protein Aggregation
10/09/2008US20080247990 Recombinant lymphocyte expressing CD16 receptor for use in targeting and destroying viral infection and tumor tissues
10/09/2008US20080247955 Detecting secreted phosphoprotein-1 and/or biomarkers; autoimmune diseases; antibodies; RNA interference
10/09/2008US20080247953 Drug screening assays; SH2 docking domains; signal sequences; immunology; cyclophilins
10/09/2008US20080247951 Angiogenesis inhibition
10/09/2008US20080247945 Interleukins; cytokines; monoclonal antibodies; bioconjugation; toxic shock syndrome
10/09/2008US20080247944 Human monoclonal antibodies; encoded by nucleic acids; anticancer agents
10/09/2008CA2683370A1 Cross-species-specific binding domain
10/09/2008CA2682851A1 A novel antigen associated with the neovasculature of tumour metastases
10/09/2008CA2682666A1 Cxcl13 antagonists and their use for the treatment of inflammatory diseases
10/09/2008CA2682521A1 Methods and compositions for the treatment of proliferative diseases
10/09/2008CA2682382A1 Non-fucosylated antibodies
10/09/2008CA2682292A1 Antibody formulation
10/09/2008CA2682266A1 Treatment of hodgkins lymphoma
10/09/2008CA2682199A1 Chloroplasts engineered to express pharmaceutical proteins in edible plants
10/09/2008CA2682170A1 Antibodies with decreased deamidation profiles
10/09/2008CA2682093A1 Antibodies, methods and kits for diagnosing and treating melanoma
10/09/2008CA2682089A1 Attenuated viruses useful for vaccines
10/09/2008CA2681752A1 Crystalline anti-human 1l-12 antibodies
10/08/2008EP1978362A2 Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity
10/08/2008EP1978097A1 Regulation of transcription factor, NF-IL6/LAP
10/08/2008EP1978036A1 A mycobacterium tuberculosis fusion protein and uses thereof
10/08/2008EP1978035A1 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/08/2008EP1978034A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same
10/08/2008EP1978033A2 Human antibodies derived from immunized xenomice
10/08/2008EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same
10/08/2008EP1978027A1 Full-length infectious cDNA clones of tick borne flavivirus
10/08/2008EP1977763A1 Antibody-containing stabilizing preparation
10/08/2008EP1977762A1 Ctgf as target for the therapy of diabetic nephropathy
10/08/2008EP1977761A2 Pharmaceutical compositions containing protein nma0939
10/08/2008EP1977760A2 Method for Treating Cervical Cancer
10/08/2008EP1977755A1 Shrimp allergen antishrimp allergen antibody and use thereof
10/08/2008EP1977747A1 Adaptive cardiac remodeling by beta-catenin downregulation
10/08/2008EP1977247A2 Methods for diagnosing and treating prostate cancer
10/08/2008EP1977015A2 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
10/08/2008EP1976987A1 Novel cancer-associated antigen
10/08/2008EP1976974A2 Pneumococcal serotypes
10/08/2008EP1976882A2 Ligands that bind il-4 and/or il-13
10/08/2008EP1976880A1 Pharmaceutical compositions with resistance to soluble cea
10/08/2008EP1976877A2 Monoclonal antibodies against amyloid beta protein and uses thereof
10/08/2008EP1976596A2 Anti-viral griffithsin compounds, compositions, and methods of use
10/08/2008EP1976594A2 Compositions and methods of use for antibodies of dickkopf-1 and/or -4
10/08/2008EP1976560A2 Thermoreversible oil-in-water emulsion
10/08/2008EP1976559A2 Influenza vaccines containing hemagglutinin and matrix proteins
10/08/2008EP1976558A2 Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
10/08/2008EP1976557A2 Chlamydial antigens
10/08/2008EP1976556A2 Neisseria meningitidis vaccines and their use
10/08/2008EP1976555A2 Drug-polymer conjugates
10/08/2008EP1976554A2 De-n-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
10/08/2008EP1976516A2 Viral hepatitis treatment
10/08/2008EP1349870B1 Compositions for the therapy and diagnosis of ovarian cancer
10/08/2008EP1262548B1 Polypeptide inducing apoptosis
10/08/2008EP1244775B1 Molecular display on multimeric protein scaffolds derived from the e2 component of the alpha-ketoacid dehydrogenase
10/08/2008EP1199565B1 Diagnostics and remedies for diseases with participation of macrocytes/macrophages
10/08/2008EP1140165B1 Improved saponin adjuvant compositions and methods relating thereto
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008EP0804580B1 Calcium binding recombinant antibody against protein c
10/08/2008EP0752005B1 Compacted nucleic acids and their delivery to cells
10/08/2008CN101282994A Anti-CD26 antibodies and methods of use thereof
10/08/2008CN101282992A Anti-myostatin antibodies
10/08/2008CN101282984A Immunogens for meningitidis-a vaccines
10/08/2008CN101282745A B-cell reduction using CD37-specific and CD20-specific binding molecules
10/08/2008CN101282744A Virus-like particles as vaccines for paramyxovirus
10/08/2008CN101282743A Bacteriocin and novel bacterium mycopremna
10/08/2008CN101282742A Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
10/08/2008CN101280316A Therapeutic vaccine for human cervical carcinoma
10/08/2008CN101280292A Virus velogen strain for porcine reproductive and respiratory syndrome, attenuated vaccine strain thereof and application thereof
10/08/2008CN101280021A Engineered protein against shrimp white spot syndrome virus, preparation and use thereof
10/08/2008CN101280016A Cocaine-and amphetamine-regulated transcript peptides single-chain antibody and application thereof
10/08/2008CN101280014A Anti-Cyclin D1 human single-chain antibody
10/08/2008CN101280013A Anti-amyloid antibodies, compositions, methods and uses
10/08/2008CN101279094A Treatment of T-cell mediated diseases
10/08/2008CN101279093A Cancer modulation antibody
10/08/2008CN101279092A Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis
10/08/2008CN100424175C Methods and compositions for treating neoplasms by ERBB3
10/08/2008CN100424095C Recombinant targeted toxin against HIV-1
10/08/2008CN100424094C Pharmaceutical compositions, and a method of preparing and isolating said pharmaceutical compositions, and use of said pharmaceutical compositions for prophylactic treatment of lesions and carcinomas
10/08/2008CN100423777C Glycoprotein compositions
10/08/2008CN100423776C Therapeutic agent
10/08/2008CN100423775C Inactivated vaccine of cow chlamydia, its preparation and inspection method
10/08/2008CN100423774C Process for preparing polysaccharide-protein conjugate vaccines
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008US7432366 Moraxella catarrhalis BASB034 polypeptides and used thereof
10/07/2008US7432364 Polynucleotide which encodes human antibody that binds to tissue inhibitors of metalloproteases; used to diagnose and treat liver & cardiac fibrosis, alcoholic liver disease, acute coronary syndrome, lupus nephritis, glomerulosclerotic renal disease, benign prostate hypertrophy, colon and lung cancer
10/07/2008US7432361 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
10/07/2008US7432359 Recombinant human antibody that specifically attacks A33-expressing tumor cells with the use of antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity based on the immune system, and for which no human anti-humanized antibody is produced
1 ... 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 ... 1823